A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Postmenopause|Breast Cancer
Sponsor: AstraZeneca